Boston Scientific Acquisition 2024. Boston scientific received a second request for information on wednesday from the federal trade commission about its proposed $3.7 billion. Bsx) generated net sales of $3.725 billion during the fourth quarter of 2023,.
Boston scientific said monday it has agreed to acquire axonics, maker of devices to treat urinary and bowel dysfunction, for $3.7 billion in cash, or $71 per share. Bsx) generated net sales of $3.725 billion during the fourth quarter of 2023,.
The Deal Is Expected To Be Completed In The First Half Of 2024.
Shares of axonics rose on monday after the company agreed be acquired for $3.7 billion in cash by boston scientific.
Bsx) Generated Net Sales Of $3.856 Billion During The First Quarter Of 2024, Growing 13.8 Percent On A Reported Basis, 15.0.
Boston scientific announces agreement to acquire axonics, inc.
8, 2024 In A Press Release.
Images References :
Will Likely Be Scrutinized By The Us Federal Trade Commission Because The.
The transaction is anticipated to close in the first half of 2024, dependent on antitrust approvals and other conditions.
Bsx) Today Announced It Has Entered Into A Definitive Agreement To Acquire.
The stock was up 20% to $69.25, its highest.
The Acquisition, Which Axonics’ Shareholders Approved Last Week, Has Been The Largest Announced Yet In 2024.